Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
P. Coates.
Clinical use of bone resorption markers.
Clin Biochemist Rev, 20 (1999), pp. 39-49
[2.]
J.A. Kanis.
Diagnosis of osteoporosis and assessment of fracture risk.
Lancet, 359 (2002), pp. 1929-1936
[3.]
R.E. Coleman.
The clinical use of bone resorption markers in patients with malignant bone disease.
Cancer, 94 (2002), pp. 2521-2533
[4.]
J. Rodríguez-Espinosa, J.M. Queraltó-Compañó.
Sobre el uso clínico de los nuevos marcadores bioquímicos del metabolismo óseo.
Med Clin (Barc), 111 (1998), pp. 259-262
[5.]
M. Kleerekoper.
Biochemical markers of bone turnover: why theory, research, and clinical practice are still in conflict.
Clin Chem, 47 (2001), pp. 1347-1349
[6.]
P.D. Delmas, R. Eastell, P. Garnero, M.J. Seibel, J. Stepan.
The use of biochemical markers of bone turnover in osteoporosis.
Osteoporos Int, (2000), pp. S2-S17
[7.]
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy.
Osteoporosis prevention, diagnosis, and therapy.
JAMA, 285 (2001), pp. 785-795
[8.]
P. Garnero, F. Bianchi, M.C. Carlier, V. Genty, N. Jacob, S. Kamel, et al.
Les marquers biologiques du remodelage osseux: variations pré-analytiques et recommendations pour leur utilisation.
Ann Biol Clin, 58 (2000), pp. 683-704
[9.]
B.E. Hillner, J.N. Ingle, J.R. Berenson, N.A. Janjan, K.S. Albain, A. Lipton, et al.
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer.
J Clin Oncol, 18 (2000), pp. 1378-1391
[10.]
Sociedad Española de Investigaciones Óseas y Metabolismo Mineral (SEIOMM).
Osteoporosis postmenopáusica.
Guía de Práctica Clínica, (2002),
[11.]
American Association of Clinical Endocrinologists.
2001 Medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis.
Endocrinol Pract, 7 (2001), pp. 294-312
[12.]
Royal College of Physicians.
Osteoporosis.
Clinical guidelines for prevention and treatment,, (2001),
[13.]
Institute for Clinical Systems Improvement.
Comité de evaluación tecnológica.
Biochemical markers for bone turnover in osteoporosis,, (2001),
[14.]
Scottish Intercollegiate Guidelines Network.
Management of osteoporosis.
A national clinical guideline,, (2002),
[15.]
H.W. Vesper, L.M. Demers, R. Eastell, P. Garnero, M. Kleerekoper, S.P. Robins, et al.
Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinolina and deoxypiridinolina.
Clin Chem, 48 (2002), pp. 220-235
[16.]
C.G. Fraser.
Biological variation: from principles to practice.
[17.]
E.K. Harris, T. Yasaka.
On the calculation of a “reference change” for comparing two consecutive measurements.
Clin Chem, 29 (1983), pp. 25-30
Copyright © 2003. Sociedad Española de Endocrinología y Nutrición